1219018

Mylan Pharmaceuticals Inc — FEI 1110315

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 18, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Morgantown, WV (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)